更多栏目
搜索
首页 列表页面
Calquence公布重要数据 阿斯利康加码血液肿瘤布局 | ...
程昊红·10小时以前
Calquence一线治疗CLL的ELEVATE TN Ⅲ期临床试验中期分析结果非常亮眼。
READ MORE
第一现场
2.0时代,勃林格殷格翰创新合作单元将登中国 | 第一现...
程昊红·2019-12-10
商务拓展、风险投资部门将与跨边界研究部门组合成全新的创新合作单元。
READ MORE
第一现场
20191210——勃林格殷格翰、赛诺菲、阿斯利康、诺华、...
新闻中心·2019-12-10
每日要闻
READ MORE
新闻
艾伯维与Scripps Research达成一系列开发合作
新闻中心·2019-12-10
AbbVie and Scripps Research announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology and fibrosis
READ MORE
新闻
默沙东27亿美元收购 ArQule
新闻中心·2019-12-10
Acquisition Further Diversifies Merck’s Oncology Pipeline with Expansion into Targeted Therapies That Treat Hematological Malignancies
READ MORE
新闻
Kite公布KTE-X19的2期临床数据
新闻中心·2019-12-10
93 Percent of Patients Treated with Investigational KTE-X19 Achieved Response, Including 67 Percent with a Complete Response
READ MORE
新闻
BMS公布Reblozyl治疗罕见血液病临床数据
新闻中心·2019-12-10
Initial results from phase 2 study evaluating an investigational use of luspatercept-aamt in myelofibrosis-associated anemia showed promising clinical activity
READ MORE
新闻
BMS与bluebird公布BCMA CAR-T疗法bb21217的1期临床数...
新闻中心·2019-12-10
CAR T persistence observed in 8/10 evaluable responders at Month 6 and 2/2 evaluable responders at Month 18
READ MORE
新闻
诺华公布Kymriah真实世界数据
新闻中心·2019-12-10
Efficacy in DLBCL confirmed results seen in the pivotal trial despite treatment of a broader population, including older and more heavily pretreated patients
READ MORE
新闻
基石药业ASH上发布CS1001-201研究最新试验数据
新闻中心·2019-12-10
CS1001在rr-ENKTL患者中表现出良好的抗肿瘤活性, 患者获得较高的CR,持久的缓解及生存获益
READ MORE
新闻
Copyright © 2016-2020 研发客.All Rights Reserved.
建议反馈: Support@PharmaDJ.com
备案/许可证编号: 沪ICP备17054709号
联系电话:021 - 88194359